Investors must take note of Acadia Pharmaceuticals Inc’s (ACAD) performance last week, which was -4.70%.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) kicked off on Monday, down -0.61% from the previous trading day, before settling in for the closing price of $17.95.